The protective immune response against Brucella involves T-cell-mediated immunity. T-lymphocyte receptors, CD28 and cytotoxic T-lymphocyte-associated protein-4 (CTLA-4), bind the same ligands, CD80 (B7-1) and CD86 (B7-2) on antigen-presenting cells and regulate T cell activation. CD28 delivers stimulatory signals whereas CTLA-4 provides inhibitory signals for T cell activation. Here, we investigated the association of four polymorphisms in CTLA4 (þ49A/G [rs231775] and À318 C/T [rs5742909]) and its ligand CD86 (þ1057 G/A [rs1129055] and þ2379G/C [rs17281995]) with brucellosis infection. The study included 153 Iranian patients with active brucellosis and 128 healthy individuals as the control group. Genotyping of the CTLA4 and CD86 variants was performed using tetra amplification refractory mutation system-polymerase chain reaction (T-ARMS-PCR) and PCRrestriction fragment length polymorphism analysis, respectively. It was found that the CTLA4 À318 CT genotype and T allele were present more frequently in cases than in controls and are therefore associated with an increased risk for brucellosis (À318 TT genotype; OR ¼ 2.544, P ¼ 0.002). Likewise, the CD86 þ1057 GA and AA genotypes and A allele were associated with an increased risk of brucellosis (þ1057 AA genotype; OR ¼ 3.81, P ¼ 0.001). However, no statistically significant difference between brucellosis patients and controls in the allele and genotype distributions of CTLA4, þ49A/G (P ¼ 0.859) and CD86, þ2379G/C (P ¼ 0.476) was found. In conclusion, CTLA4 À318 CT genotype and Tallele and the CD86 þ057 GA and AA genotypes and A allele play roles as risk factors for developing brucellosis infection in Iran.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.